NU-ICRF 505
Alternative Names: NU/ICRF 505Latest Information Update: 08 Apr 2003
At a glance
- Originator Western General Hospital
- Class Anthraquinones; Antineoplastics; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer